Skip to content

AMPIO PHARMACEUTICALS, INC.: filings

Every AMPIO PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 51 filings, each linked to its SEC index.

Filing record ends 2024-03-27

The latest filing in this captured record is a 10-K filed 2024-03-27. No later filing is in the SEC companyfacts record captured on 2026-09-22. AMPIO PHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-K2024-03-27fiscal FY 202332620001558370-24-004090
10-Q2023-11-14fiscal Q3 202331900001558370-23-019022
10-Q2023-08-08fiscal Q2 202331860001558370-23-013963
10-Q2023-05-08fiscal Q1 202330580001558370-23-008557
10-K2023-03-27fiscal FY 202233660001558370-23-004723
10-Q2022-11-14fiscal Q3 202233990001558370-22-017798
10-Q2022-08-09fiscal Q2 202233950001558370-22-012937
10-Q2022-05-16fiscal Q1 202233670001558370-22-008967
10-K2022-03-29fiscal FY 202132640001558370-22-004619
10-Q2021-11-10fiscal Q3 202130910001558370-21-015493
10-Q2021-08-04fiscal Q2 202130870001558370-21-010209
10-Q2021-05-05fiscal Q1 202130610001558370-21-005918
10-K2021-03-03fiscal FY 202032640001558370-21-002314
10-Q2020-11-03fiscal Q3 202030910001558370-20-012324
10-Q2020-07-31fiscal Q2 202031890001558370-20-008834
10-Q2020-05-06fiscal Q1 202031630001558370-20-005444
10-K2020-02-21fiscal FY 201933660001558370-20-001123
10-Q2019-11-07fiscal Q3 201932950001558370-19-010403
10-Q2019-08-09fiscal Q2 201930870001558370-19-007896
10-Q2019-05-10fiscal Q1 201925510001558370-19-004876
10-K2019-03-18fiscal FY 201825500001558370-19-002244
10-Q2018-11-14fiscal Q3 201826660001144204-18-059508
10-Q2018-08-14fiscal Q2 201825620001144204-18-044117
10-Q2018-05-10fiscal Q1 201824490001144204-18-026799
10-K2018-03-06fiscal FY 2017281120001144204-18-013087
10-Q2017-11-07fiscal Q3 201725600001144204-17-056691
10-Q2017-08-09fiscal Q2 201722540001144204-17-041377
10-Q2017-05-12fiscal Q1 201724480001144204-17-026953
10-K2017-03-16fiscal FY 2016281080001144204-17-015100
10-Q2016-11-08fiscal Q3 201625640001144204-16-132259
10-Q2016-08-02fiscal Q2 201624570001193125-16-668317
10-Q2016-05-06fiscal Q1 201625490001193125-16-581067
10-K2016-02-26fiscal FY 2015311240001193125-16-479780
10-Q2015-11-06fiscal Q3 201525610001193125-15-370152
10-Q2015-08-07fiscal Q2 201523570001193125-15-282073
10-Q2015-05-08fiscal Q1 201523480001193125-15-178525
10-K2015-02-24fiscal FY 2014291130001193125-15-059240
10-Q2014-11-07fiscal Q3 201427660001193125-14-402262
10-Q2014-08-08fiscal Q2 201425640001193125-14-303313
10-Q2014-05-07fiscal Q1 201431860001193125-14-187670
10-K2014-02-14fiscal FY 2013341510001193125-14-054391
10-Q2013-11-08fiscal Q3 201330940001193125-13-433742
10-Q2013-08-09fiscal Q2 201330940001193125-13-329340
10-Q2013-05-03fiscal Q1 201329750001193125-13-199383
10-K2013-03-06fiscal FY 201231970001193125-13-092219
10-Q2012-11-02fiscal Q3 201228880001193125-12-449322
10-Q2012-08-03fiscal Q2 201228880001193125-12-333874
10-Q2012-05-04fiscal Q1 201228650001193125-12-211382
10-K2012-02-09fiscal FY 201128700001193125-12-049358
10-Q2011-11-01fiscal Q3 201128850001193125-11-290197
10-Q2011-08-12fiscal Q2 201126760001193125-11-221399

Inspect the source

Entity
AMPIO PHARMACEUTICALS, INC. / CIK 0001411906
Captured
SEC response SHA-256
661bdc81760eff21f73144c4212b3daf37fe49f00b5469e6e153f0c2138a63e3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001411906.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))